Status:
COMPLETED
Efficacy of Raltegravir in a Large Urban HIV Clinical Population in Milan
Lead Sponsor:
Università Vita-Salute San Raffaele
Collaborating Sponsors:
Ospedale San Raffaele
Conditions:
HIV Infections
Eligibility:
All Genders
18-90 years
Brief Summary
This will be a retrospective analysis of efficacy, safety and tolerability of raltegravir as part of an optimized therapy in a clinical setting. Follow-up is calculated from the treatment initiation ...
Eligibility Criteria
Inclusion
- Subjects who received raltegravir and were previously exposed to NRTIs, NNRTIs, PIs, regardless of the stage of HIV disease at the start of the treatment.
Exclusion
- None
Key Trial Info
Start Date :
December 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT01467349
Start Date
December 1 2011
End Date
December 1 2012
Last Update
February 11 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Infectious Diseases Department
Milan, Milan, Italy, 20127